Solventum Corporation (SOLV) Return on Invested Capital (ROIC): 17.76%
Is Solventum Corporation’s return on invested capital (ROIC) high or low?
Solventum Corporation's return on invested capital (ROIC) of 17.76% is 83% above its 5-year average of 9.71%, near the high end of its 5-year range (0.00%–17.76%).
As of Friday, June 12, 2026. 44.33% above its 12-month average of 12.30%.
SOLV Return on Invested Capital (ROIC) Chart
SOLV Average Return on Invested Capital (ROIC) Chart
SOLV Current vs Average Return on Invested Capital (ROIC) Chart
SOLV Return on Invested Capital (ROIC) Metrics
RETURN ON INVESTED CAPITAL (ROIC)
17.76%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
12.30%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
11.68%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
9.71%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
9.71%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
9.71%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
9.71%
CURRENT VS TTM AVG
+44.33%
CURRENT VS 3Y AVG
+52.02%
CURRENT VS 5Y AVG
+82.97%
CURRENT VS 10Y AVG
+82.97%
CURRENT VS 15Y AVG
+82.97%
CURRENT VS 20Y AVG
+82.97%
SOLV Competitors' Return on Invested Capital (ROIC)
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Solventum Corporation (SOLV) | $13.72B | 17.76% | 12.30% | 11.68% | 9.71% |
| Align Technology, Inc. (ALGN) | $12.64B | 9.94% | 9.96% | 10.13% | 11.66% |
| Baxter International Inc. (BAX) | $10.58B | -1.79% | -0.86% | -2.61% | 0.30% |
| Hologic, Inc. (HOLX) | $16.97B | 7.35% | 8.59% | 9.78% | 13.56% |
| Charles River Laboratories International, Inc. (CRL) | $9.06B | 8.36% | 4.65% | 6.09% | 6.66% |
| Tempus AI, Inc. (TEM) | $8.65B | -10.29% | -59.01% | -58.33% | -53.58% |
| Bio-Rad Laboratories, Inc. (BIO) | $7.91B | 2.04% | 2.21% | 2.35% | 2.39% |
| Moderna, Inc. (MRNA) | $19.70B | -29.70% | -31.12% | -12.69% | 0.19% |
| Hims & Hers Health, Inc. (HIMS) | $6.19B | 6.02% | 9.35% | -2.77% | -9.72% |
| BioNTech SE (BNTX) | $22.39B | -3.14% | -4.79% | 9.55% | 20.42% |
Capital Efficiency
ROIC
17.8%
ROE
28.8%
Solventum Corporation Return on Invested Capital (ROIC) Formula & Definition
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Solventum Corporation Return on Invested Capital (ROIC) FAQ
- What is the return on invested capital (ROIC) for Solventum Corporation (SOLV)?
- The return on invested capital (ROIC) for SOLV stock is 17.76%.
- Is Solventum Corporation's return on invested capital (ROIC) high or low?
- Solventum Corporation's return on invested capital (ROIC) of 17.76% is 83% above its 5-year average of 9.71%, near the high end of its 5-year range (0.00%–17.76%).
- What is the TTM average return on invested capital (ROIC) for Solventum Corporation (SOLV)?
- The TTM average return on invested capital (ROIC) for SOLV stock is 12.30%.
- What is the 3Y average return on invested capital (ROIC) for Solventum Corporation (SOLV)?
- The 3Y average return on invested capital (ROIC) for SOLV stock is 11.68%.
- What is the 5Y average return on invested capital (ROIC) for Solventum Corporation (SOLV)?
- The 5Y average return on invested capital (ROIC) for SOLV stock is 9.71%.
- What is the 10Y average return on invested capital (ROIC) for Solventum Corporation (SOLV)?
- The 10Y average return on invested capital (ROIC) for SOLV stock is 9.71%.
- What is the 15Y average return on invested capital (ROIC) for Solventum Corporation (SOLV)?
- The 15Y average return on invested capital (ROIC) for SOLV stock is 9.71%.
- What is the 20Y average return on invested capital (ROIC) for Solventum Corporation (SOLV)?
- The 20Y average return on invested capital (ROIC) for SOLV stock is 9.71%.
Solventum Corporation Return on Invested Capital (ROIC) History
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 17.76% |
| 2024-12-31 | 6.85% |
| 2023-12-31 | 11.18% |
| 2022-12-31 | 10.94% |
| 2021-12-31 | 11.51% |
| 2020-12-31 | 0.00% |
Related Metrics
About Solventum Corporation
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Bryan C. Hanson